Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects (clinicaltrials.gov) - Feb 21, 2022 - P1 | N=88 | Recruiting | Sponsor: Chong Kun Dang Pharmaceutical | Trial completion date: May 2021 ➔ Sep 2022 | Trial primary completion date: May 2021 ➔ Sep 2022
First-in-human • Trial completion date • Trial primary completion date
|